FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harry Erba

Research Profile

Disorders

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Concepts & Ideas

Physiology

Phenomena

Nucleic Acid Hybridization

Living Beings

Salamandridae

Co-author Network

Publications

TOP 3
Bruce J Roth; Wolfram Samlowski; Gary K Schwartz; Jamie H Von Roenn; Sylvia Adams; Carol A Aghajanian; Peter Bach; Fadi Braiteh; Marcia S Brose; Lee M Ellis; Harry P Erba; Daniel J George; Mark R Gilbert; Joseph O Jacobson; Lada Krilov; Eric C Larsen; Stuart M Lichtman; Ann H Partridge; Jyoti D Patel; David I Quinn; Leslie L Robison; Nicholas J Vogelzang
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
Uma Borate; Harry P Erba; Devin Absher; Boris Pasche
Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.
David Claxton; Harry P Erba; Stefan Faderl; Janice Gabrilove; Pritesh J Gandhi; Dirk Huebner; Hagop Kantarjian; Tibor Kovacsovics; Roger M Lyons; Martha Arellano
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harry Erba (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bruce J Roth; Wolfram Samlowski; Gary K Schwartz; Jamie H Von Roenn; Sylvia Adams; Carol A Aghajanian; Peter Bach; Fadi Braiteh; Marcia S Brose; Lee M Ellis; Harry P Erba; Daniel J George; Mark R Gilbert; Joseph O Jacobson; Lada Krilov; Eric C Larsen; Stuart M Lichtman; Ann H Partridge; Jyoti D Patel; David I Quinn; Leslie L Robison; Nicholas J Vogelzang
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):131-61.
2012: Uma Borate; Harry P Erba; Devin Absher; Boris Pasche
Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.
Expert review of anticancer therapy 2012;12(10):1289-97.
2012: David Claxton; Harry P Erba; Stefan Faderl; Janice Gabrilove; Pritesh J Gandhi; Dirk Huebner; Hagop Kantarjian; Tibor Kovacsovics; Roger M Lyons; Martha Arellano
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia.
Leukemia & lymphoma 2012;53(3):435-40.
2011: Meng Li; Peter Ouillette; Nickolas Papadopoulos; Bert Vogelstein; Dale Bixby; Roxane Collins; Harry P Erba; Yuchen Jiao; Kenneth W Kinzler; Sami Malek
Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.
Blood 2011;118(22):5914-7.
2011: John Magenau; Sophie Paczesny; Attaphol Pawarode; Edward M Peres; Pavan Reddy; Jennifer Sanks; Hiromi Tobai; Gregory Yanik; Thomas Braun; Sung Won Choi; Kojo Seys John Elenitoba-Johnson; Harry P Erba; James L M Ferrara; David Frame; Andrew Harris; Dawn Jones; Carrie L Kitko; Lisa Ann Kujawski; John E Levine; Shin Mineishi
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.
Blood 2011;118(15):4258-64.
2011: Harry P Erba; Dat C Pham; Ho Vu; Robert Zaiden; Shawn Tai
Improving frontline treatment for chronic myeloid leukemia: emerging evidence for use of nilotinib and dasatinib.
Clinical advances in hematology & oncology : H&O 2011;9(10):734-45.
2011: Kamlai Saiya-Cork; Roxane Collins; Brian Parkin; Peter Ouillette; Erlene Kuizon; Lisa Ann Kujawski; Harry P Erba; Erica Campagnaro; Kerby Shedden; Mark S Kaminski; Sami Malek
A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2679-92.
2011: Mark Levis; Farhad Ravandi; Eunice S Wang; Maria R Baer; Alexander Perl; Steven Coutre; Harry P Erba; Robert K Stuart; Michele Baccarani; Larry D Cripe; Martin S Tallman; Giovanna Meloni; Lucy A Godley; Amelia A Langston; Sergio Amadori; Ian D Lewis; Arnon Nagler; Richard Stone; Karen Yee; Anjali Advani; Dan Douer; W Wiktor-Jedrzejczak; Gunnar Juliusson; Mark R Litzow; Stephen Petersdorf; Miguel Sanz; Hagop M Kantarjian; Takashi X Sato; Lothar Tremmel; Debra M Bensen-Kennedy; Donald Small; B Douglas Smith
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
Blood 2011;117(12):3294-301.
2011: Mikkael A Sekeres; Jaroslaw P Maciejewski; Harry P Erba; Manuel Afable; Ricki Englehaupt; Ronald Sobecks; Anjali Advani; Sherry Seel; Josephine Chan; Matt E Kalaycio
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
Cancer 2011;117(6):1253-61.
2011: Meng Wang; Bruno C Medeiros; Harry P Erba; Daniel J DeAngelo; Francis J Giles; Ronan T Swords
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer.
Expert opinion on therapeutic targets 2011;15(3):253-64.
2010: Brian Parkin; Harry P Erba; Peter Ouillette; Diane Roulston; Anjali Purkayastha; Judith E Karp; Moshe Talpaz; Lisa Ann Kujawski; Sajid Shakhan; Cheng Li; Kerby Shedden; Sami Malek
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
Blood 2010;116(23):4958-67.
2010: Harry P Erba
Has there been progress in the treatment of older patients with acute myeloid leukemia?
Best practice & research. Clinical haematology 2010;23(4):495-501.
2010: Brian Parkin; Peter Ouillette; Yin Wang; Yan Liu; Whitney Wright; Diane Roulston; Anjali Purkayastha; Amanda Dressel; Judith E Karp; Paula L Bockenstedt; Ammar Al-Zoubi; Moshe Talpaz; Lisa Ann Kujawski; Yang Liu; Kerby Shedden; Sajid Shakhan; Cheng Li; Harry P Erba; Sami Malek
NF1 inactivation in adult acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(16):4135-47.
2010: Jianting Long; Brian Parkin; Peter Ouillette; Dale Bixby; Kerby Shedden; Harry P Erba; Shaomeng Wang; Sami Malek
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.
Blood 2010;116(1):71-80.
2010: Hagop M Kantarjian; Harry P Erba; David F Claxton; Martha Arellano; Roger M Lyons; Tibor Kovascovics; Janice Gabrilove; Michael Craig; Dan Douer; Michael Maris; Stephen Petersdorf; Paul J Shami; Andrew M Yeager; Stephen Eckert; Rekha Abichandani; Stefan Faderl
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):549-55.
2010: Thomas R Chauncey; Holly Gundacker; Mazyar Shadman; Alan F List; Shaker R Dakhil; Harry P Erba; Marilyn L Slovak; I-Ming Chen; Cheryl L Willman; Kenneth J Kopecky; Frederick R Appelbaum
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.
British journal of haematology 2010;148(1):48-58.
2009: Susan O'Brien; Ellin Berman; Hossein Borghaei; Daniel J Deangelo; Marcel P Devetten; Steven Devine; Harry P Erba; Jason Gotlib; Madan Jagasia; Joseph O Moore; Tariq Mughal; Javier Pinilla-Ibarz; Jerald P Radich; Neil P Shah Md; Paul J Shami; B Douglas Smith; David S Snyder; Martin S Tallman; Moshe Talpaz; Meir Wetzler
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):984-1023.
2009: Jerald P Radich; Andrew D Zelenetz; Wing C Chan; Carlo M Croce; Myron S Czuczman; Harry P Erba; Sandra J Horning; Jane Houldsworth; B Douglas Smith; David S Snyder; Hema M Sundar; Meir Wetzler; Jane N Winter
NCCN task force report: molecular markers in leukemias and lymphomas.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7 Suppl 4():S1-34, quiz S35-6.
2009: Jeffrey Crawford; James Armitage; Lodovico Balducci; Charles L Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Marti Goemann; Mark L Heaney; Sally Htoy; Susan Hudock; Dwight D Kloth; David J Kuter; Gary H Lyman; Laura Boehnke Michaud; Sarah C Miyata; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Myeloid growth factors.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(1):64-83.
2008: Margaret R O'Donnell; Frederick R Appelbaum; Steven E Coutre; Lloyd E Damon; Harry P Erba; James Foran; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Peter Maslak; Michael Millenson; Joseph O Moore; Farhad Ravandi; Friedrich Schuening; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman; Eunice S Wang; Frank L White
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):962-93.
2008: Peter L Greenberg; Eyal Attar; Minoo Battiwalla; John M Bennett; Clara D Bloomfield; Carlos M DeCastro; H Joachim Deeg; Harry P Erba; James M Foran; Guillermo Garcia-Manero; Steven D Gore; David Head; Lori J Maness; Michael Millenson; Stephen D Nimer; Margaret R O'Donnell; Hussain I Saba; Paul J Shami; Kathy Spiers; Richard M Stone; Martin S Tallman; Peter Westervelt
Myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):902-26.
2008: Lisa Ann Kujawski; Peter Ouillette; Harry P Erba; Chris Saddler; Andrzej J Jakubowiak; Mark S Kaminski; Kerby Shedden; Sami Malek
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Blood 2008;112(5):1993-2003.
2008: Peter Ouillette; Harry P Erba; Lisa Ann Kujawski; Mark S Kaminski; Kerby Shedden; Sami Malek
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Cancer research 2008;68(4):1012-21.
2008: Chris Saddler; Peter Ouillette; Lisa Ann Kujawski; Sanjeev Shangary; Moshe Talpaz; Mark S Kaminski; Harry P Erba; Kerby Shedden; Shaomeng Wang; Sami Malek
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
Blood 2008;111(3):1584-93.
2007: Colin F Greineder; Patrick W Nelson; Amanda L Dressel; Harry P Erba; John Younger
In vitro and in silico analysis of annexin V binding to lymphocytes as a biomarker in emergency department sepsis studies.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2007;14(9):763-71.
2007: Nadine Shehab; Daryl D DePestel; Emily R Mackler; Curtis D Collins; Kathleen Welch; Harry P Erba
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Pharmacotherapy 2007;27(7):970-9.
2007: Susan O'Brien; Ellin Berman; Kapil N Bhalla; Edward A Copelan; Marcel P Devetten; Peter D Emanuel; Harry P Erba; Peter L Greenberg; Joseph O Moore; Donna Przepiorka; Jerald P Radich; Russell J Schilder; Paul Shami; B Douglas Smith; David S Snyder; Robert J Soiffer; Martin S Tallman; Moshe Talpaz; Meir Wetzler
Chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(5):474-96.
2007: Jeffrey Crawford; Betsy Althaus; James Armitage; Lodovico Balducci; Charles L Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Mark L Heaney; Sally Htoy; Dwight D Kloth; Gary H Lyman; Wells A Messersmith; Laura Boehnke Michaud; Sarah C Miyata; Amy Robbins; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Myeloid growth factors. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):188-202.
2007: Harry P Erba
Prognostic factors in elderly patients with AML and the implications for treatment.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():420-8.
2006: Peter L Greenberg; Maria R Baer; John M Bennett; Clara D Bloomfield; Carlos M De Castro; H Joachim Deeg; Marcel P Devetten; Peter D Emanuel; Harry P Erba; Eli Estey; James Foran; Steven D Gore; Michael Millenson; Willlis H Navarro; Stephen D Nimer; Margaret R O'Donnell; Hussain I Saba; Kathy Spiers; Richard M Stone; Martin S Tallman
Myelodysplastic syndromes clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):58-77.
2006: Margaret R O'Donnell; Frederick R Appelbaum; Maria R Baer; John C Byrd; Steven E Coutre; Lloyd E Damon; Harry P Erba; Eli Estey; James Foran; Jeffrey Lancet; Lori J Maness; Peter Maslak; Michael Millenson; Joseph O Moore; Donna Przepiorka; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):16-36.
2005: Susan O'Brien; Ellin Berman; Kapil N Bhalla; Edward A Copelan; Marcel P Devetten; Peter D Emanuel; Harry P Erba; Peter L Greenberg; Joseph O Moore; Donna Przepiorka; Jerald P Radich; Russell J Schilder; Paul Shami; B Douglas Smith; David S Snyder; Robert J Soiffer; Martin S Tallman; Moshe Talpaz; Meir Wetzler
Chronic myelogenous leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(6):732-55.
2004: Harry P Erba
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Current hematology reports 2004;3(1):47-53.
2003: Patricia Anne Ganz; Carol M Moinpour; Donna K Pauler; Alice B Kornblith; Ellen R Gaynor; Stanley P Balcerzak; Gretchen S Gatti; Harry P Erba; Sheryl McCoy; Oliver W Press; Richard I Fisher
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3512-9.
2003: Harry P Erba
Recent progress in the treatment of myelodysplastic syndrome in adult patients.
Current opinion in oncology 2003;15(1):1-9.
2000: Frederick R Appelbaum; Maria R Baer; M H Carabasi; Steven E Coutre; Harry P Erba; Eli Estey; MJ Glenn; E H Kraut; Peter Maslak; Michael Millenson; Carole B Miller; Hussain I Saba; R Stone; Martin S Tallman
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Oncology (Williston Park, N.Y.) 2000;14(11A):53-61.
2000: Ellin Berman; Reginald Clift; Edward A Copelan; Peter D Emanuel; Harry P Erba; MJ Glenn; Peter L Greenberg; Richard J Jones; S O'Brien; Hussain I Saba; Russell J Schilder; D S Snyder; Robert J Soiffer; Martin S Tallman; M Wetzler; F Ravandi-Kashani; Andrew Lamb; Moshe Talpaz
NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
Oncology (Williston Park, N.Y.) 2000;14(11A):229-40.
2000: Giuseppe Paciocco; Eduardo Bossone; Harry P Erba; Melvyn Rubenfire
Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
The Canadian journal of cardiology 2000;16(8):1007-12.
1994: Jon C Aster; Warren S Pear; Robert P Hasserjian; Harry P Erba; F Davi; B Luo; M Scott; David Baltimore; Jeffrey Sklar
Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch.
Cold Spring Harbor symposia on quantitative biology 1994;59():125-36.
1988: A Taylor; Harry P Erba; G E Muscat; Larry Kedes
Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains.
Genomics 1988;3(4):323-36.
1988: S Y Ng; Harry P Erba; G Latter; Larry Kedes; J Leavitt
Modulation of microfilament protein composition by transfected cytoskeletal actin genes.
Molecular and cellular biology 1988;8(4):1790-4.
1988: Harry P Erba; R Eddy; T Shows; Larry Kedes; Peter W Gunning
Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes.
Molecular and cellular biology 1988;8(4):1775-89.
1988: G S Cross; C Wilson; Harry P Erba; Hugh R Woodland
Cytoskeletal actin gene families of Xenopus borealis and Xenopus laevis.
Journal of molecular evolution 1988;27(1):17-28.
1986: Harry P Erba; Peter W Gunning; Larry Kedes
Nucleotide sequence of the human gamma cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes.
Nucleic acids research 1986;14(13):5275-94.
1981: E C Stephenson; Harry P Erba; J G Gall
Histone gene clusters of the newt notophthalmus are separated by long tracts of satellite DNA.
Cell 1981;24(3):639-47.
1981: E C Stephenson; Harry P Erba; J G Gall
Characterization of a cloned histone gene cluster of the newt Notophthalamus viridescens.
Nucleic acids research 1981;9(10):2281-95.
1981: J G Gall; E C Stephenson; Harry P Erba; M O Diaz; G Barsacchi-Pilone
Histone genes are located at the sphere loci of newt lampbrush chromosomes.
Chromosoma 1981;84(2):159-71.
1980: J M Varley; HC Macgregor; Harry P Erba
Satellite DNA is transcribed on lampbrush chromosomes.
Nature 1980;283(5748):686-8.
1980: J M Varley; HC Macgregor; I Nardi; C Andrews; Harry P Erba
Cytological evidence of transcription of highly repeated DNA sequences during the lampbrush stage in Triturus cristatus carnifex.
Chromosoma 1980;80(3):289-307.